ReviewSports medicine (Auckland, N.Z.)2003
Drugs for increasing oxygen and their potential use in doping: a review.
Review in Sports medicine (Auckland, N.Z.), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 62 citations in OpenAlex.
- Advances in nanomaterials for treatment of hypoxic tumor.National science review · 2021Article
- Speed trends in male distance running.PloS one · 2014Article
- Hepcidin and sports anemia.Cell & bioscience · 2014Review
- From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?Sports medicine (Auckland, N.Z.) · 2013Review
- Erythropoietin use and abuse.Indian journal of endocrinology and metabolism · 2012Article
- Variability in training-induced skeletal muscle adaptation.Journal of applied physiology (Bethesda, Md. : 1985) · 2011Review
- Article
- Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.British journal of pharmacology · 2008Review
- Oxygen delivery enhancers: past, present, and future.Journal of endocrinological investigation · 2008Review
- Blood doping : infusions, erythropoietin and artificial blood.Sports medicine (Auckland, N.Z.) · 2007Article
- The promise and predicament of cosmetic neurology.Journal of medical ethics · 2006Review
- Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.Sports medicine (Auckland, N.Z.) · 2005Review
- Gene doping in sports.Sports medicine (Auckland, N.Z.) · 2004Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blood oxygenation is a fundamental factor in optimising muscular activity. Enhancement of oxygen delivery to tissues is associated with a substantial improvement in athletic performance, particularly in endurance sports. Progress in medical research has led to the identification of new chemicals for the treatment of severe anaemia. Effective and promising molecules have been created and sometimes used for doping purposes. The aim of this review is to present methods, and drugs, known to be (or that might be) used by athletes to increase oxygen transport in an attempt to improve endurance capacity. These methods and drugs include: (i) blood transfusion; (ii) endogenous stimulation of red blood cell production at altitude, or using hypoxic rooms, erythropoietins (EPOs), EPO gene therapy or EPO mimetics; (iii) allosteric effectors of haemoglobin; and (iv) blood substitutes such as modified haemoglobin solutions and perfluorochemicals. Often, new chemicals are used before safety tests have been completed and athletes are taking great health risks. Such new chemicals have also created the need for new instrumental strategies in doping control laboratories, but not all of these chemicals are detectable. Further progress in analytical research is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.